Study shows new infant RSV antibody shot highly effective, making Delaware Valley pediatricians hopeful for more protections next fall
New federal data shows that a first-of-its-kind treatment designed to temporarily protect infants from severe respiratory syncytial virus, or RSV, has been highly effective.